Casdin Capital

Latest statistics and disclosures from Casdin Capital's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Casdin Capital

Companies in the Casdin Capital portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Invitae (NVTA) 15.2 $514M +36% 12M 41.81
Biolife Solutions Com New (BLFS) 8.8 $297M +27% 7.4M 39.89
Fate Therapeutics (FATE) 8.2 $277M 3.1M 90.93
EXACT Sciences Corporation (EXAS) 5.8 $197M NEW 1.5M 132.49
Blueprint Medicines (BPMC) 5.1 $174M 1.6M 112.15
Relay Therapeutics (RLAY) 4.7 $158M 3.8M 41.56
Twist Bioscience Corp (TWST) 4.2 $141M 1.0M 141.29
Pacific Biosciences of California (PACB) 3.8 $130M +11% 5.0M 25.94
Denali Therapeutics (DNLI) 3.3 $110M 1.3M 83.76
Agios Pharmaceuticals (AGIO) 3.0 $103M +35% 2.4M 43.33
Alnylam Pharmaceuticals (ALNY) 3.0 $101M +25% 780k 129.97
Codexis (CDXS) 2.8 $95M +8% 4.3M 21.83
Sarepta Therapeutics (SRPT) 2.7 $90M 530k 170.49
Caredx (CDNA) 2.6 $87M 1.2M 72.45

Setup an alert

Casdin Capital will file the next quarterly 13-HR in about 1 months. Would you like to be notified?

Revolution Medicines (RVMD) 1.9 $65M 1.6M 39.59
Constellation Pharmceticls I (CNST) 1.5 $51M +82% 1.8M 28.80
Generation Bio (GBIO) 1.4 $46M 1.6M 28.35
Dermtech Ord ord (DMTK) 1.3 $44M -4% 1.4M 32.44
Burning Rock Biotech Sponsored Ads (BNR) 1.3 $44M 1.9M 23.10
Adaptive Biotechnologies Cor (ADPT) 1.2 $42M 713k 59.13
Crispr Therapeutics Namen Akt (CRSP) 1.2 $41M 266k 153.11
Bluebird Bio (BLUE) 1.2 $40M 915k 43.27
Adverum Biotechnologies (ADVM) 1.2 $40M +32% 3.7M 10.84
Beigene Sponsored Adr (BGNE) 1.1 $39M 150k 258.39
Beam Therapeutics (BEAM) 1.1 $38M NEW 460k 81.64
Global Blood Therapeutics In (GBT) 1.1 $37M +117% 860k 43.31
4d Molecular Therapeutics In (FDMT) 1.0 $32M NEW 781k 41.45
Magenta Therapeutics (MGTA) 0.8 $26M 3.3M 7.84
Zai Lab Adr (ZLAB) 0.8 $26M 190k 135.34
Iovance Biotherapeutics (IOVA) 0.8 $26M +89% 550k 46.40
Alector (ALEC) 0.7 $25M 1.7M 15.13
Allogene Therapeutics (ALLO) 0.7 $24M 945k 25.24
908 Devices (MASS) 0.7 $23M NEW 407k 56.95
Taysha Gene Therapies Com Shs (TSHA) 0.6 $22M 820k 26.54
Oric Pharmaceuticals (ORIC) 0.6 $20M +139% 602k 33.85
Berkeley Lts (BLI) 0.5 $18M 200k 89.41
Kronos Bio (KRON) 0.5 $17M NEW 583k 29.87
Sangamo Biosciences (SGMO) 0.5 $17M 1.1M 15.60
Fulcrum Therapeutics (FULC) 0.4 $15M -13% 1.2M 11.71
Amyris Call Option (AMRS) 0.4 $12M -72% 2.0M 6.17
Syndax Pharmaceuticals (SNDX) 0.3 $10M NEW 450k 22.24
Black Diamond Therapeutics (BDTX) 0.3 $9.3M 289k 32.05
Turning Point Therapeutics I (TPTX) 0.3 $9.1M 75k 121.85
Seer Com Cl A (SEER) 0.2 $8.4M NEW 150k 56.14
Abcellera Biologics (ABCL) 0.2 $8.0M NEW 200k 40.24
Dyne Therapeutics (DYN) 0.2 $7.8M 370k 21.00
Stoke Therapeutics (STOK) 0.2 $7.4M 120k 61.93
Foghorn Therapeutics (FHTX) 0.1 $4.4M NEW 216k 20.27
Bristol-myers Squibb Right 99/99/9999 0.1 $4.3M 6.3M 0.69
Codiak Biosciences (CDAK) 0.1 $2.5M NEW 77k 32.30
C4 Therapeutics Com Stk (CCCC) 0.0 $1.3M NEW 40k 33.12

Past Filings by Casdin Capital

SEC 13F filings are viewable for Casdin Capital going back to 2015

View all past filings